NCT01739335View on ClinicalTrials.gov

Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2012

Primary Completion Date

September 19, 2016

Study Completion Date

November 16, 2016

Conditions

Stress Disorders, Post-Traumatic

Interventions

DRUG

Mifepristone Oral Tablet [Korlym]

2 Mifepristone 300 MG Oral Tablets once daily (600mg total) for 7 days

DRUG

Placebo Oral Tablet

2 Placebo Oral Tablets once daily for 7 days

Trial Locations (5)

10468

James J. Peters VA Medical Center, The Bronx

27705

Durham VA Medical Center, Durham

28144

Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury

87108

Albuquerque VA Medical Center, Albuquerque

92161

VA San Diego Healthcare System, San Diego

All Listed Sponsors

lead

VA Office of Research and Development

FED

NCT01739335 - Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone | Biotech Hunter | Biotech Hunter